anmelden
SMIM
3.096,51
PKT
-10,14
PKT
-0,33
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.05.12 | Adecco SA buy | ING | |
| 09.05.12 | Swiss Prime Site hold | Vontobel Research | |
| 08.05.12 | Adecco SA buy | Sarasin Research | |
| 08.05.12 | Adecco SA buy | Vontobel Research | |
| 07.05.12 | Roche buy | Vontobel Research | |
| 04.05.12 | Adecco SA outperform | Exane-BNP Paribas SA | |
| 03.05.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 03.05.12 | Swisscom neutral | Nomura | |
| 03.05.12 | Swisscom hold | Vontobel Research | |
| 03.05.12 | Avolta (ex Dufry) hold | Vontobel Research | |
| 03.05.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 02.05.12 | Swisscom neutral | Sarasin Research | |
| 02.05.12 | Swisscom hold | Vontobel Research | |
| 30.04.12 | Swisscom neutral | Nomura | |
| 27.04.12 | SGS SA buy | Vontobel Research | |
| 26.04.12 | Straumann hold | Vontobel Research | |
| 25.04.12 | Temenos equal-weight | Morgan Stanley | |
| 25.04.12 | Lindt underperform | Cheuvreux SA | |
| 25.04.12 | Temenos buy | Vontobel Research | |
| 25.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 24.04.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 24.04.12 | Swisscom equal-weight | Morgan Stanley | |
| 23.04.12 | Swisscom buy | Société Générale Group S.A. (SG) | |
| 19.04.12 | Schindler buy | Sarasin Research | |
| 17.04.12 | Kühne + Nagel International neutral | Sarasin Research | |
| 16.04.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 13.04.12 | EMS-CHEMIE buy | Sarasin Research | |
| 13.04.12 | Roche outperform | Exane-BNP Paribas SA | |
| 12.04.12 | Roche outperform | Cheuvreux SA | |
| 12.04.12 | Swatch (I) buy | Sarasin Research | |
| 11.04.12 | Roche neutral | Nomura | |
| 10.04.12 | Sonova kaufen | Die Actien-Börse | |
| 05.04.12 | Roche outperform | Credit Suisse Group | |
| 04.04.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 03.04.12 | Julius Bär equal-weight | Morgan Stanley | |
| 02.04.12 | Barry Callebaut neutral | Sarasin Research | |
| 30.03.12 | Roche neutral | WestLB AG | |
| 30.03.12 | Roche outperform | Exane-BNP Paribas SA | |
| 30.03.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 29.03.12 | Roche overweight | J.P. Morgan Cazenove |
